đź“‹ FDA Reference
interface module iddd
Stoeckert Instrumente
Summary: The Interface Module IDDD is a Class 1 medical device used in tumor ablation procedures. It is primarily utilized by oncologists and interventional radiologists.
FDA Clearance Information
Pathway
510K
Number
K992635 ↗
Decision Date
December 20, 1999
Product Code
KRI
Device Class
Class 1
Evidence
0 studies
The Interface Module IDDD was cleared through the FDA 510(k) pathway on December 20, 1999. It is manufactured by Stoeckert Instrumente and classified as a Class 1 device.
What It Is
The Interface Module IDDD is a medical device designed to facilitate tumor ablation procedures. It acts as a critical component in the delivery of energy to ablate tumor tissues. The device is engineered to integrate seamlessly with ablation systems, ensuring precise control and monitoring during procedures.
Clinical Applications
This device is commonly used in interventional oncology settings for the treatment of various tumors. It is particularly useful in minimally invasive procedures where precise ablation is required, such as in liver, lung, or kidney tumors. The device is typically employed in hospital settings by specialists in oncology and interventional radiology.
Indications for Use
The FDA-cleared indications for the Interface Module IDDD involve its use in tumor ablation procedures. It is intended for patients requiring localized treatment of tumors, providing a targeted approach to destroy cancerous tissues.
Practical Considerations
The Interface Module IDDD is compatible with a range of ablation systems, offering flexibility in clinical use. It is important for clinicians to ensure proper integration with existing equipment and to be familiar with the device's operational protocols for optimal performance.
Frequently Asked Questions
What is Interface Module IDDD used for?
The Interface Module IDDD is used in tumor ablation procedures to assist in the precise delivery of energy to ablate tumor tissues.
What specialties typically use this device?
This device is typically used by oncologists and interventional radiologists in hospital settings.
What are the FDA-cleared indications?
The device is indicated for use in tumor ablation procedures, specifically for the localized treatment of tumors.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.